Jodas is a global, specialty, innovation-driven, emerging, generic pharmaceutical company, that is asserting itself among the world’s foremost pharmaceutical companies. We began our journey of growth in the year 2008 in India, and today Jodas is a modern, research-driven organization that has quality and affordability at the heart of its activities.

Our Core Therapeutic Segments:

Anti Infectives (Injectables)
Anti Cancer (Injectables & Orals)
Contrast Media – Injectables
Critical Care (Injectables & Orals)

Our dedicated team of healthcare professionals strives to bring specialty, high-quality, effective, and affordable generic formulations to the market, touching millions of lives with good health. Jodas has approved products in 30+ countries with State-of-the-art world-class manufacturing facilities and has successfully commercialized 19.4 million Injectables in the year 2022, with unparalleled customer satisfaction.

The future endeavor is to be a Global generic player, validating our commitment “ONE STEP BETTER”, to fulfill the unmet medical needs of the healthcare community around the Globe with specialty generic formulations of uncompromising quality.

Pharmaceutical

Jodas Expoim Pvt. Ltd.

Piyush Gupta

Shashi Shanker Parsad Singh

Krishna M.

Tathagata Dutta

Sudip Majumdar

Prriya Dubey

Anand Vijaywargia

Operations and Project Management

Leadership Team

Research and Development

Quality and Safety Assurance

Teams at Jodas Expoim Pvt. Ltd.

Operations and Project Management

Leadership Team

Research and Development

Quality and Safety Assurance